Participants who developed AD were older, less educated, were more likely to be APOE ε4 allele carriers, and had higher IL-6 PRS scores at 7 out of 10 GWAS significance thresholds, compared to those who remained AD-free. This evidence concerns the gene IL6 and Alzheimer disease.